Search Medical Condition
Please enter condition
Please choose location from dropdown

Kiriat Bialik, Israel Clinical Trials

A listing of Kiriat Bialik, Israel clinical trials actively recruiting patients volunteers.

RESULTS

Found (330) clinical trials

Non-invasive Melanoma Assessment Using a Topical Fluorescence Reagent and Optical Imaging

A topical agent is applied to suspicious skin lesions and imaged. The images are analyzed to provide a score that correlates with the probability for the presence of melanoma in the lesion.

Phase N/A

0.0 miles

Learn More »

A Long-Term Registry of Humira (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)

This is a registry study to evaluate the long-term safety and effectiveness of adalimumab in patients with moderately to severely active UC who are treated as recommended in the product label.

Phase N/A

0.0 miles

Learn More »

Direction Modulation of Muscle Synergies After a Stroke

Introduction: Upper extremity function after a stroke is impaired and characterized by abnormal, stereotypical and uncoordinated movement pattern. Decreased neural drive in the damaged corticospinal system causing a decreased agonists motor units firing, spasticity, impaired motor coordination. A more comprehensive understanding of the way our brain controls and regulates limb-movements, ...

Phase N/A

5.17 miles

Learn More »

Error Augmentation Training Post Stroke

Post-stroke individuals continue to suffer from significant motor impairments years after the stroke. Motor recovery is usually limited to the first 6 month after the stroke, in which the majority of improvements occur at the first three months. Error augmentation (EA) training using a robotic apparatus was suggested to enhance ...

Phase N/A

5.17 miles

Learn More »

Use of Existing Fibroblast Cells to Convert to Induced Pluripotent Stem Cells

The potential to reprogram somatic cells into an embryonic state raises multiple basic research questions related both to the process of reprogramming and the properties of iPS cells. We will use various approaches to study the molecular mechanisms and processes that occur during reprogramming. We will use various experimental systems ...

Phase N/A

5.47 miles

Learn More »

Development of iPS From Donated Somatic Cells of Patients With Neurological Diseases

The derivation of human iPS cells (1-5) open new avenues to model human diseases since it may now be possible to develop iPS cells from the fibroblasts or other somatic cells of patients with various conditions. These iPS cells may be directed to differentiate into the cells which are affected ...

Phase N/A

5.47 miles

Learn More »

Study to Evaluate Tezepelumab in Adults & Adolescents With Severe Uncontrolled Asthma

This is a multicentre, randomized, double-blind, placebo controlled, parallel group study designed to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma on medium to high-dose ICS and at least one additional asthma controller medication with or without OCS. Approximately 1060 subjects will be ...

Phase

5.57 miles

Learn More »

Vedolizumab Subcutaneous Long-Term Open-Label Extension Study

The drug being tested in this study is called vedolizumab subcutaneous (vedolizumab SC). Vedolizumab SC is being tested to assess its long-term safety and effectiveness in treating participants with UC or CD. This study will look at the long-term side effects and response/remission of UC and CD in participants who ...

Phase

5.57 miles

Learn More »

Scleral Fixation of BunnyLens With GoreTex Suture- Initial Results

4 point scleral fixation of PC- IOL (Posterior Chamber-PC) BunnyLens with Gore-Tex sutures is a surgical technique for implanting IOL in patients with capsular support absence, due to trauma, abnormal anterior chamber, IOL dislocation, or ciliary zonule defect. The 4 point fixation enables to align the PC- IOL with minimal ...

Phase N/A

5.57 miles

Learn More »

This is a randomized, double-blind, placebo-controlled, multicenter phase III study. The study population will consist of approximately 1300 subjects with metastatic hormone sensitive prostate cancer (mHSPC), who will be randomized (1:1 ratio) to receive 600 mg (2 x 300 mg tablets) of darolutamide (ODM-201)/placebo twice daily with food, equivalent to ...

Phase

5.67 miles

Learn More »